Warfarin-resistant left ventricular thrombus completely dissolved by rivaroxaban
Authors:
- 2 November 2018
- journal article
- research article
- Published by IMR Press in British Journal of Hospital Medicine
- Vol. 79 (11) , 648-649
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trialsThe Lancet Haematology, 2014
- Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolismThrombosis Journal, 2014
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive SummaryCirculation, 2013
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationEuropean Heart Journal, 2012
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillationEuropean Heart Journal, 2012
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- Frequency of Left Ventricular Thrombus in Patients With Anterior Wall Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention and Dual Antiplatelet TherapyThe American Journal of Cardiology, 2010
- Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention eraAmerican Heart Journal, 2009
- Clinical, imaging, and pathological characteristics of left ventricular thrombus: A comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validationAmerican Heart Journal, 2006
- Left ventricular thrombus in acute myocardial infarctionEuropean Heart Journal, 1996